Amélie Valérie Guitart (Amelie V Guitart, Amélie V Guitart)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer 5 (6) (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer 5 (6) (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer 5 (6) (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer 5 (6) (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer (2024)
Marine Dupont, Mathilde Huart, Claire Lauvinerie, Audrey Bidet, Amélie Valérie Guitart, Arnaud Villacreces, Isabelle Vigon, Vanessa Desplat, Ali El-Habhab, Arnaud Pigneux, Zoran Ivanovic, Philippe Brunet de la Grange, Pierre-Yves Dumas, Jean Max Pasquet
Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells. Cancers 14 (2) (2022)
Laura Rodriguez, Pascale Duchez, Nicolas Touya, Christelle Debeissat, Amélie Valérie Guitart, Jean Max Pasquet, Marija Vlaski-Lafarge, Philippe Brunet de la Grange, Zoran Ivanovic
α-Tocopherol Attenuates Oxidative Phosphorylation of CD34+ Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance. Biomolecules 11 (4) (2021)
Pierre-Yves Dumas, Arnaud Villacreces, Amélie Valérie Guitart, Ali El-Habhab, Layal Massara, Olivier Mansier, Audrey Bidet, Delphine Martineau, Solene Fernandez, Thibaut Leguay, Arnaud Pigneux, Isabelle Vigon, Jean-Max Pasquet, Vanessa Desplat
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, Amélie Valérie Guitart, Noël Milpied, Arnaud Pigneux, Isabelle Vigon, Jean Max Pasquet, Pierre-Yves Dumas
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How? International journal of molecular sciences 20 (14) (2019)
Amélie Valérie Guitart, Andrew J Finch, Kamil R Kranc
Ca2+tapulting HSCs into action. The Journal of experimental medicine 215 (8) (2018)